G9a expression was enriched in tumor-initiating cells (TICs) of non-small cell lung cancer (NSCLC), and loss of G9a led to reduced proliferation and sphere-forming capacity of TICs. The gene discussed is EHMT2; the disease is non-small cell lung carcinoma.